Pharvaris technical ops chief sells 46,400 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Pharvaris N.V. (PHVS) reported that Chief Technical Ops Officer Stefan Andreas Abele exercised stock options for 45,000 shares of common stock at an exercise price of $16.40 per share on September 15, 2026, leaving 44,500 options outstanding from that grant. The acquired shares were largely sold the same day in a cashless exercise, including 45,000 shares at a weighted average price of $38.1375 per share and 1,400 shares at a weighted average price of $39.2411 per share, with prices in each sale reported as ranges. No Rule 10b5-1 trading plan is indicated.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
Abele Stefan Andreas
Role
Chief Technical Ops Officer
Sold
46,400 shs ($1.77M)
Approx. gross sale proceeds
$1.77M
Approx. exercise cost
$738K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F3 | 45,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 45,000 | $16.40 | $738K |
| Sale | Common Stock F1 | 45,000 | $38.1375 | $1.72M |
| Sale | Common Stock F2 | 1,400 | $39.2411 | $55K |
Holdings After Transaction:
Stock Option (Right to Buy) — 44,500 contracts (Direct);
Common Stock — 39,068 shares (Direct)
Footnotes (3)
- F1. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $38.00 to $38.35. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F2. The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $39.2150 to $39.27 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F3. 25% of the option vested on November 15, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.
Key Figures
Options exercised: 45,000 shares
Option exercise price: $16.40 per share
Shares sold (first block): 45,000 shares
+5 more
8 metrics
Options exercised
45,000 shares
Stock options for Pharvaris N.V. common stock exercised on September 15, 2026
Option exercise price
$16.40 per share
Exercise price for the 45,000 stock options converted into common stock
Shares sold (first block)
45,000 shares
Common stock sold on September 15, 2026 in connection with cashless exercise
Weighted average sale price (first block)
$38.1375 per share
Based on multiple transactions ranging from $38.00 to $38.35
Shares sold (second block)
1,400 shares
Common stock sold that was acquired upon vesting of restricted stock units
Weighted average sale price (second block)
$39.2411 per share
Based on multiple transactions ranging from $39.2150 to $39.27
Options remaining from grant
44,500 options
Total stock options reported as held directly after the 45,000-share exercise
Option expiration date
November 15, 2033
Expiration date of the exercised stock option grant
Key Terms
cashless exercise, weighted average sale price, restricted stock units, stock option
4 terms
cashless exercise financial
"shares were sold in connection with the exercise of stock options in a cashless exercise transaction"
A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.
weighted average sale price financial
"The reported price represents a weighted average sale price for shares sold"
restricted stock units financial
"The shares sold were acquired upon vesting of restricted stock units on various dates"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock option financial
"Stock Option (Right to Buy) with an exercise price of $16.40 per share"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PHVS insider Stefan Andreas Abele report on this Form 4?
He exercised 45,000 stock options for Pharvaris N.V. common shares at $16.40 per share on September 15, 2026, then reported sales totaling 46,400 common shares the same day in market or private transactions.
How many Pharvaris (PHVS) options does the insider retain after these transactions?
After exercising 45,000 options, Stefan Andreas Abele reports 44,500 stock options remaining from that option grant. The option has an exercise price of $16.40 per share and an expiration date of November 15, 2033.
Was the PHVS insider transaction a cashless exercise of options?
Yes. Footnotes state the 45,000-share sale was made "in connection with the exercise of stock options in a cashless exercise transaction," meaning sale proceeds covered the option exercise cost rather than separate cash payment.
Were any Pharvaris (PHVS) restricted stock units involved in these sales?
Yes. A 1,400-share sale at a weighted average price of $39.2411 per share is described as shares "acquired upon vesting of restricted stock units on various dates," and then sold in multiple transactions within a narrow price range.
Was a Rule 10b5-1 trading plan used for these PHVS insider trades?
No. The filing’s Rule 10b5-1 checkbox is not marked as affirming a plan, and the footnotes do not state that the transactions were made under any Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
